Possible Synergic Effect of Angiotensin-I Converting Enzyme Gene Insertion/Deletion Polymorphism and Angiotensin-II Type-1 Receptor 1166A/C Gene Polymorphism on Ischemic Heart Disease in Patients with Kawasaki Disease

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Pediatric Research

• Publication date

  2004-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1203/01.PDR.0000139426.16381.C8PMID 15295089
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical trials report

  2004cited by this paper
• Angiotensin I-converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene.

  2003cited by this paper
• Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse.

  2003cited by this paper
• Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

  2003cited by this paper
• The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: Part II: AT(1) receptor regulation.

  2002cited by this paper
• The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis.

  2002cited by this paper
• The AT1-Type Angiotensin Receptor in Oxidative Stress and Atherogenesis

  2002cited by this paper
• Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism Does Not Influence the Restenosis Rate after Coronary Stent Implantation

  2002cited by this paper
• Vascular Remodeling in Hypertension: Roles of Apoptosis, Inflammation, and Fibrosis

  2001cited by this paper
• Cytokine Modulation with Immune γ-Globulin in Peripheral Blood of Normal Children and Its Implications in Kawasaki Disease Treatment

  2001cited by this paper
• Left Ventricular Hypertrophy With Exercise and ACE Gene Insertion/Deletion Polymorphism: A Randomized Controlled Trial With Losartan

  2001cited by this paper
• Incidence survey of Kawasaki disease in 1997 and 1998 in Japan.

  2001cited by this paper
• Feasibility of Percutaneous Transluminal Coronary Angioplasty to Patients with Kawasaki Disease as an Early Management Strategy

  2001cited by this paper
• Angiotensin II type 1 receptor−153A/G and 1166A/C gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects

  2001cited by this paper
• Remodeling of coronary artery lesions due to Kawasaki disease: comparison of arteriographic and immunohistochemical findings.

  2000cited by this paper
• The insertion/deletion polymorphism of the angiotensin-converting enzyme gene determines coronary vascular tone and nitric oxide activity.

  2000cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

  2000cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.

  2000cited by this paper
• Vascular injury causes neointimal formation in angiotensin II type 1a receptor knockout mice.

  1999cited by this paper
• Are Angiotensin Converting Enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease?

  1999cited by this paper
• Dual determination of angiotensin-converting enzyme and angiotensin-II type 1 receptor genotypes as predictors of restenosis after coronary angioplasty.

  1998cited by this paper
• Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: a major risk factor and a marker of risk for coronary stent restenosis.

  1998cited by this paper
• ACE I/D gene polymorphism: presence of the ACE D allele increases the risk of coronary artery disease in younger individuals.

  1998cited by this paper
• Angiotensin II type 1 receptor gene polymorphism is associated with increase of left ventricular mass but not with hypertension.

  1998cited by this paper
• Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension

  1997cited by this paper
• High incidence of angiotensin I converting enzyme genotype II in Kawasaki disease patients with coronary aneurysm

  1997cited by this paper
• ACE gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study.

  1997cited by this paper
• Silent myocardial ischemia in Kawasaki disease: evaluation of percutaneous transluminal coronary angioplasty by dobutamine stress testing.

  1997cited by this paper
• The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction.

  1997cited by this paper
• Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: the CORGENE study

  1996cited by this paper
• Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives.

  1996cited by this paper
• Influence of angiotensin II type 1 receptor polymorphism on aortic stiffness in never-treated hypertensive patients.

  1995cited by this paper
• A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease.

  1995cited by this paper
• Angiotensin converting enzyme as a genetic risk factor for coronary artery spasm. Implication in the pathogenesis of myocardial infarction.

  1995cited by this paper
• Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension.

  1994cited by this paper
• Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction.

  1994cited by this paper
• Plasma angiotensin-converting enzyme activity and carotid wall thickening.

  1994cited by this paper
• Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese.

  1994cited by this paper
• Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

  1992cited by this paper
• Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions.

  1990cited by this paper
• Colorimetry of angiotensin-I converting enzyme activity in serum.

  1981cited by this paper
• Pathology of Kawasaki disease: I. Pathology and morphogenesis of the vascular changes.

  1979cited by this paper

• Regression effect of renin–angiotensin–aldosterone system inhibitors on Kawasaki disease patients with coronary artery aneurysm: a prospective, observational study

  2024cites this paper
• Overview of an Association of Renin-Angiotensin System with Kawasaki Disease

  2023cites this paper
• Association of ACE gene polymorphisms with in-stent restenosis by stent type (biomime, supraflex, xience)

  2023cites this paper
• Association ofACE Gene Polymorphisms with In- Stent Restenosis by Stent Type (Biomime, Supra ex, Xience)

  2023cites this paper
• A protective erythropoietin evolutionary landscape, NLRP3 inflammasome regulation, and multisystem inflammatory syndrome in children

  2022cites this paper
• Association Between the Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism and Avascular Necrosis of the Femoral Head

  2019cites this paper
• Genetics of immunoglobulin-A vasculitis (Henoch-Schönlein purpura): An updated review.

  2018cites this paper
• Angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to Kawasaki disease: a meta-analysis

  2017cites this paper
• Impact of I/D polymorphism of angiotensin-converting enzyme (ACE) gene on myocardial infarction susceptibility among young Moroccan patients

  2017cites this paper
• The role of infection in Kawasaki syndrome

  2013cites this paper
• Understanding the Pathogenesis of Kawasaki Disease by Network and Pathway Analysis

  2013influential citation
• Differential Expression of miR-145 in Children with Kawasaki Disease

  2013cites this paper
• Mercury Promotes Catecholamines Which Potentiate Mercurial Autoimmunity and Vasodilation: Implications for Inositol 1,4,5-Triphosphate 3-Kinase C Susceptibility in Kawasaki Syndrome

  2013cites this paper
• Lack of association of genetic polymorphisms of angiotensin converting enzyme 1 and angiotensin II type 1 receptor with breast cancer risk in Iranian population

  2013cites this paper
• Associations between the angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to vasculitis: a meta-analysis

  2012cites this paper
• Responsible Genetic Factors for Vasculitis in Kawasaki Disease

  2011cites this paper
• Genetic polymorphisms in Kawasaki disease

  2011cites this paper
• CASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwanese children

  2011cites this paper
• Guidelines for Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease (JCS 2008)

  2010cites this paper
• Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008)--digest version.

  2010cites this paper
• Renin-angiotensin-aldosterone system gene polymorphisms in coronary artery bypass graft surgery patients

  2010cites this paper
• Kawasaki disease: update on pathogenesis

  2010cites this paper
• CHAPTER 52 – Kawasaki Disease

  2010cites this paper
• Molecular Genetics of Kawasaki Disease

  2009cites this paper
• Association between the angiotensin-converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms and breast cancer among Brazilian women

  2009cites this paper
• Susceptibility genes for Kawasaki disease: toward implementation of personalized medicine

  2009cites this paper
• Kawasaki disease: an overview

  2008cites this paper
• Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: A HuGE review

  2008cites this paper
• Vasculitis induced by immunization with Bacillus Calmette‐Guérin followed by atypical mycobacterium antigen: a new mouse model for Kawasaki disease

  2007cites this paper
• Kawasaki Disease: Four Case Reports of Cardiopathy with an Institutional and Literature Review

  2007cites this paper
• Coexistence of angiotensin II type-1 receptor A1166C and angiotensin-converting enzyme D/D polymorphism suggests susceptibility for small-vessel-associated ischemic stroke

  2007cites this paper
• Angiotensin II type-1 receptor A1166C polymorphism is associated with increased risk of ischemic stroke in hypertensive smokers

  2007cites this paper
• Genetic variants predisposing to cardiovascular disease

  2006cites this paper
• Insertion/Deletion Polymorphism of Angiotensin Converting Enzyme Gene in Kawasaki Disease

  2006cites this paper
• Le polymorphisme du gène de l'enzyme de conversion de l'angiotensine et le risque de l'infarctus du myocarde en Tunisie

  2005cites this paper
• Pathogenesis and treatment of Kawasaki's disease

  2005cites this paper
• Korean Circulation Journal

  year unknowncites this paper